|
|
Volumn 361, Issue 20, 2009, Pages 1994-1996
|
|
Isolated tumor cells in breast cancer [1]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
HORMONE RECEPTOR;
ESTROGEN RECEPTOR;
TRASTUZUMAB;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
HER2 PROTEIN, HUMAN;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER HORMONE THERAPY;
DISEASE FREE SURVIVAL;
HUMAN;
LETTER;
PRIORITY JOURNAL;
TUMOR VOLUME;
AXILLARY LYMPH NODE;
CANCER GRADING;
LYMPH NODE DISSECTION;
LYMPH NODE METASTASIS;
SENTINEL LYMPH NODE BIOPSY;
ADJUVANT CHEMOTHERAPY;
BREAST TUMOR;
EPIDEMIOLOGY;
FEMALE;
NOTE;
PROPORTIONAL HAZARDS MODEL;
TREATMENT OUTCOME;
METHODOLOGY;
PATHOLOGY;
ANTINEOPLASTIC AGENTS, HORMONAL;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
CONFOUNDING FACTORS (EPIDEMIOLOGY);
FEMALE;
HUMANS;
PROPORTIONAL HAZARDS MODELS;
TREATMENT OUTCOME;
LYMPHATIC METASTASIS;
RECEPTOR, ERBB-2;
RESEARCH DESIGN;
SENTINEL LYMPH NODE BIOPSY;
|
|
EID: 70449641339
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc091861 Document Type: Letter |
|
Times cited : (105)
|
|
References (3)
|
